Patients | 4/26/2023

Dear Patient,

Welcome to This website provides information and editorials about asthma and chronic obstructive pulmonary disease (COPD) for patients. 

This section of requires registration and is developed only for patients using prescription medication for asthma or COPD in a dry powder inhaler called Easyhaler®. If your medication is provided in any other type of dry powder inhalers (the other commonly used dry powder inhaler devices are e.g. Turbuhaler, Diskus, Ellipta, Genuair, Breezhaler, Handihaler, DuoResp, Forspiro, Spiromax, Twisthaler, Novolizer), please, contact respective company and their websites.

After registration this section of provides you with:

  • User instructions of your prescription medication
  • Education of inhalation technique
  • Answers to frequently asked questions and patient information leaflet of respective product
  • Peak Expiratory Flow (PEF) measurement instructions and PEF follow-up form (country specific)

Currently this content is offered in the following countries. To access the content you need to enter the batch number of your prescription medication.

Belgium  Belgium - French - Dutch

Czech Republic  Czech Republic potilaille  Finland

Betegeknek  Hungary

Ireland  Ireland voor patiënten  Netherlands 

Poland  Poland

Spain  Spain

United Kingdom  United Kingdom


Orion Corporation is a globally operating Finnish pharmaceutical company. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. The dry powder inhaler developed at Orion is in the core of our respiratory therapy area.